연구성과로 돌아가기
2020 연구자 정보 (341 / 997)
※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
| Author Name | 제1저자 여부 | 교신저자 여부 | Address | ResearcherID | ORCID | Paper Title | WoS Edition | 최상위 JCR(%) | WoS Category | Related Email |
|---|---|---|---|---|---|---|---|---|---|---|
|
Bai, Li-Yuan (Bai, LY) |
China Med Univ, China Med Univ Hosp, Div Hematol & Oncol, Dept Internal Med, Taichung, Taiwan China Med Univ, China Med Univ Hosp, Dept Internal Med, Div Hematol & Oncol, Taichung, Taiwan |
|
|
[JCR상위 17.6] Exploratory subgroup analysis of patients with prior trastuzumab use in the ATTRACTION-2 trial: a randomized phase III clinical trial investigating the efficacy and safety of nivolumab in patients with advanced gastric/gastroesophageal junction cancer [JCR상위 17.6] A phase 3 study of nivolumab in previously treated advanced gastric or gastroesophageal junction cancer (ATTRACTION-2): 2-year update data |
SCIE | 17.6 | GASTROENTEROLOGY & HEPATOLOGY;ONCOLOGY | nboku@ncc.go.jp; | ||
|
Boku, Narikazu (Boku, N) |
교신저자 |
Natl Canc Ctr, Div Gastrointestinal Med Oncol, Chuo Ku, 5-1-1 Tsukiji, Tokyo 1040045, Japan Natl Canc Ctr, Div Gastrointestinal Med Oncol, Chuo Ku, 5-1-1 Tsukiji, Tokyo, Japan |
|
|
[JCR상위 17.6] Exploratory subgroup analysis of patients with prior trastuzumab use in the ATTRACTION-2 trial: a randomized phase III clinical trial investigating the efficacy and safety of nivolumab in patients with advanced gastric/gastroesophageal junction cancer [JCR상위 17.6] A phase 3 study of nivolumab in previously treated advanced gastric or gastroesophageal junction cancer (ATTRACTION-2): 2-year update data |
SCIE | 17.6 | GASTROENTEROLOGY & HEPATOLOGY;ONCOLOGY | nboku@ncc.go.jp; | |
|
Chao, Yee (Chao, Y) |
Taipei Vet Gen Hosp, Dept Oncol, Taipei, Taiwan Taipei Vet Gen Hosp, Taipei, Taiwan |
|
|
[JCR상위 17.6] Exploratory subgroup analysis of patients with prior trastuzumab use in the ATTRACTION-2 trial: a randomized phase III clinical trial investigating the efficacy and safety of nivolumab in patients with advanced gastric/gastroesophageal junction cancer [JCR상위 17.6] A phase 3 study of nivolumab in previously treated advanced gastric or gastroesophageal junction cancer (ATTRACTION-2): 2-year update data [JCR상위 1.9] Margetuximab plus pembrolizumab in patients with previously treated, HER2-positive gastro-oesophageal adenocarcinoma (CP-MGAH22-05): a single-arm, phase 1b-2 trial |
SCIE | 1.9 |
GASTROENTEROLOGY & HEPATOLOGY;ONCOLOGY ONCOLOGY |
nboku@ncc.go.jp; dcatenac@bsd.uchicago.edu; |
||
|
Chen, Jen-Shi (Chen, JS) |
Chang Gung Univ, Linkou Chang Gung Mem Hosp, Dept Internal Med, Div Hematol & Oncol, Taoyuan, Taiwan |
GLV-3349-2022 Chen, Jen-Shi |
|
[JCR상위 17.6] Exploratory subgroup analysis of patients with prior trastuzumab use in the ATTRACTION-2 trial: a randomized phase III clinical trial investigating the efficacy and safety of nivolumab in patients with advanced gastric/gastroesophageal junction cancer [JCR상위 17.6] A phase 3 study of nivolumab in previously treated advanced gastric or gastroesophageal junction cancer (ATTRACTION-2): 2-year update data |
SCIE | 17.6 | GASTROENTEROLOGY & HEPATOLOGY;ONCOLOGY | nboku@ncc.go.jp; | ||
|
Chen, Li-Tzong (Chen, LT) |
Natl Cheng Kung Univ, Natl Hlth Res Inst, Natl Inst Canc Res, Tainan, Taiwan Natl Cheng Kung Univ, Natl Inst Canc Res, Natl Hlth Res Inst, Tainan, Taiwan Natl Cheng Kung Univ, Natl Cheng Kung Univ Hosp, Dept Internal Med, Tainan, Taiwan |
|
|
[JCR상위 17.6] Exploratory subgroup analysis of patients with prior trastuzumab use in the ATTRACTION-2 trial: a randomized phase III clinical trial investigating the efficacy and safety of nivolumab in patients with advanced gastric/gastroesophageal junction cancer [JCR상위 17.6] A phase 3 study of nivolumab in previously treated advanced gastric or gastroesophageal junction cancer (ATTRACTION-2): 2-year update data |
SCIE | 17.6 | GASTROENTEROLOGY & HEPATOLOGY;ONCOLOGY | nboku@ncc.go.jp; | ||
|
Cheol Chung, Hyun (Chung, HC) |
Yonsei Univ, Yonsei Univ Hlth Syst, Song Dang Inst Canc Res, Yonsei Canc Ctr,Div Med Oncol,Coll Med, Seoul, South Korea |
AFB-8969-2022 Chung, Hyun Cheol |
0000-0002-0920-9471 Chung, Hyun |
[JCR상위 17.6] Exploratory subgroup analysis of patients with prior trastuzumab use in the ATTRACTION-2 trial: a randomized phase III clinical trial investigating the efficacy and safety of nivolumab in patients with advanced gastric/gastroesophageal junction cancer | SCIE | 17.6 | GASTROENTEROLOGY & HEPATOLOGY;ONCOLOGY | nboku@ncc.go.jp; | ||
|
Chin, Keisho (Chin, K) |
Hosp Japanese Fdn Canc Res, Inst Canc, Dept Gastroenterol, Tokyo, Japan Japanese Fdn Canc Res, Dept Gastroenterol, Canc Inst Hosp, Tokyo, Japan |
|
|
[JCR상위 17.6] Exploratory subgroup analysis of patients with prior trastuzumab use in the ATTRACTION-2 trial: a randomized phase III clinical trial investigating the efficacy and safety of nivolumab in patients with advanced gastric/gastroesophageal junction cancer [JCR상위 17.6] A phase 3 study of nivolumab in previously treated advanced gastric or gastroesophageal junction cancer (ATTRACTION-2): 2-year update data |
SCIE | 17.6 | GASTROENTEROLOGY & HEPATOLOGY;ONCOLOGY | nboku@ncc.go.jp; | ||
|
Choi, Boram (Choi, B) |
Seoul Natl Univ, Coll Med, Canc Res Inst, 101 Daehak Ro, Seoul, South Korea |
|
|
[JCR상위 17.6] microRNA-30a arbitrates intestinal-type early gastric carcinogenesis by directly targeting ITGA2 | SCIE | 17.6 | GASTROENTEROLOGY & HEPATOLOGY;ONCOLOGY | eunyoung.choi@vumc.org;jim.goldenring@vumc.org;hkyang@snu.ac.kr; | ||
|
Choi, Eunyoung (Choi, E) |
교신저자 |
Vanderbilt Univ, Sch Med, Nashville VA Med Ctr, Nashville, TN 37212 USA Vanderbilt Univ, Sch Med, Dept Surg, Nashville, TN 37212 USA Vanderbilt Univ, Sch Med, Epithelial Biol Ctr, Med Ctr, MRB 4 10435F,2213 Garland Ave, Nashville, TN 37232 USA |
KQU-5508-2024 CHOI, EUNYOUNG |
0000-0002-1501-1568 Choi, Eunyoung |
[JCR상위 17.6] microRNA-30a arbitrates intestinal-type early gastric carcinogenesis by directly targeting ITGA2 | SCIE | 17.6 | GASTROENTEROLOGY & HEPATOLOGY;ONCOLOGY | eunyoung.choi@vumc.org;jim.goldenring@vumc.org;hkyang@snu.ac.kr; | |
|
Chung, Hyun Cheol (Chung, HC) |
Yonsei Univ, Yonsei Univ Hlth Syst, Song Dang Inst Canc Res, Div Med Oncol,Yonsei Canc Ctr,Coll Med, Seoul, South Korea |
AFB-8969-2022 Chung, Hyun Cheol |
0000-0002-0920-9471 Chung, Hyun |
[JCR상위 17.6] A phase 3 study of nivolumab in previously treated advanced gastric or gastroesophageal junction cancer (ATTRACTION-2): 2-year update data | SCIE | 17.6 | GASTROENTEROLOGY & HEPATOLOGY;ONCOLOGY | nboku@ncc.go.jp; | ||
|
Goldenring, James R. (Goldenring, JR) |
교신저자 |
Vanderbilt Univ, Sch Med, Nashville VA Med Ctr, Nashville, TN 37212 USA Vanderbilt Univ, Sch Med, Dept Surg, Nashville, TN 37212 USA Vanderbilt Univ, Sch Med, Epithelial Biol Ctr, Med Ctr, MRB 4 10435F,2213 Garland Ave, Nashville, TN 37232 USA Vanderbilt Univ, Sch Med, Cell & Dev Biol, Nashville, TN 37212 USA |
|
|
[JCR상위 17.6] microRNA-30a arbitrates intestinal-type early gastric carcinogenesis by directly targeting ITGA2 | SCIE | 17.6 | GASTROENTEROLOGY & HEPATOLOGY;ONCOLOGY | eunyoung.choi@vumc.org;jim.goldenring@vumc.org;hkyang@snu.ac.kr; | |
|
Hamamoto, Yasuo (Hamamoto, Y) |
Keio Univ, Keio Canc Ctr, Sch Med, Tokyo, Japan |
AAA-9941-2022 Hamamoto, Yasuo |
0000-0002-5737-122X Hamamoto, Yasuo |
[JCR상위 17.6] Exploratory subgroup analysis of patients with prior trastuzumab use in the ATTRACTION-2 trial: a randomized phase III clinical trial investigating the efficacy and safety of nivolumab in patients with advanced gastric/gastroesophageal junction cancer [JCR상위 17.6] A phase 3 study of nivolumab in previously treated advanced gastric or gastroesophageal junction cancer (ATTRACTION-2): 2-year update data |
SCIE | 17.6 | GASTROENTEROLOGY & HEPATOLOGY;ONCOLOGY | nboku@ncc.go.jp; | ||
|
Jeong, Hui Yeong (Jeong, HY) |
Kyungpook Natl Univ, Dept Hort, Daegu 41566, South Korea Kyungpook Natl Univ, Dept Hort, Daegu, South Korea |
|
|
Regeneration of Genetically Stable Plants from in Vitro Vitrified Leaves of Different Carnation Cultivars [JCR상위 17.6] Overexpression of theRaphanus sativus RsMYB1using the flower-specific promoter (InMYB1) enhances anthocyanin accumulation in flowers of transgenic Petunia and their hybrids |
SCIE | 17.6 | AGRONOMY;GENETICS & HEREDITY;HORTICULTURE;PLANT SCIENCES |
thumiu.luv@gmail.com;aunghtaynaing2005@gmail.com;dmg03062@naver.com;ckkim@knu.ac.kr; ckkim@knu.ac.kr; |
||
|
Kang, Hyun Hee (Kang, HH) |
Kyungpook Natl Univ, Dept Hort, Daegu, South Korea Kyungpook Natl Univ, Dept Hort Sci, Daegu 41566, South Korea |
|
|
[JCR상위 17.6] Overexpression of theRaphanus sativus RsMYB1using the flower-specific promoter (InMYB1) enhances anthocyanin accumulation in flowers of transgenic Petunia and their hybrids [JCR상위 16.7] Protoplast Isolation and Shoot Regeneration from Protoplast-Derived Callus ofPetunia hybridaCv. Mirage Rose |
SCIE | 16.7 |
AGRONOMY;GENETICS & HEREDITY;HORTICULTURE;PLANT SCIENCES BIOLOGY |
ckkim@knu.ac.kr; a3220641@naver.com;aunghtaynaing2005@gmail.com;ckkim@knu.ac.kr; |
||
|
Kang, Won Ki (Kang, WK) |
Sungkyunkwan Univ, Samsung Med Ctr, Dept Med, Div Hematol Oncol,Sch Med, Seoul, South Korea |
|
|
[JCR상위 17.6] A phase 3 study of nivolumab in previously treated advanced gastric or gastroesophageal junction cancer (ATTRACTION-2): 2-year update data | SCIE | 17.6 | GASTROENTEROLOGY & HEPATOLOGY;ONCOLOGY | nboku@ncc.go.jp; |
페이지 이동: